Skip to main content
. Author manuscript; available in PMC: 2011 Aug 1.
Published in final edited form as: Breast Cancer Res Treat. 2009 Nov 10;123(1):51–58. doi: 10.1007/s10549-009-0631-7

Table 2. Univariate and multivariate analyses of OS and DFS.

Univariate analysis


Overall survival
Disease free survival
Variable HR 95% CI P value HR 95% CI P value


Hormonal Treatment 0.36 0.18 to 0.69 0.002 0.37 0.19 to 0.73 0.004
ER expression 0.44 0.24 to 0.80 0.007 0.48 0.25 to 0.89 0.020
GPR30/ER patterns 0.65 0.47 to 0.88 0.01 0.67 0.48 to 0.94 0.02
GPR30/ER status 0.43 0.20 to 0.94 0.03 0.47 0.19 to 1.13 0.09
ER/PR patterns 0.78 0.63 to 0.97 0.03 0.81 0.65 to 1.02 0.07
Her-2/ER/PR status 2.12 1.70 to 3.84 0.01 2.20 1.17 to 4.14 0.02
EGFR expression 1.93 1.07 to 3.46 0.03 1.74 0.91 to 3.30 0.09
Multivariate analysis
ER expression 0.14 0.03 to 0.59 0.008 0.17 0.03 to 0.78 0.023